Publicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (52)

2024

  1. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

  2. Hospital pharmacy towards 2030

    Farmacia Hospitalaria, Vol. 48, pp. S52-S58

  3. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 10, pp. 1325-1338

  4. Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning

    RMD Open, Vol. 10, Núm. 1

  5. Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model

    Frontiers in Pharmacology, Vol. 15

2023

  1. Postoperative Critical Care Admission Was Not Associated with Improved Postoperative Outcomes in Elective Colorectal Surgery: Secondary Analysis Of POWER Trial

    Journal of Gastrointestinal Surgery, Vol. 27, Núm. 10, pp. 2187-2198

  2. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

  3. Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study

    International Journal of Cardiology, Vol. 382, pp. 40-45

  4. Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 8, pp. 577-584

  5. Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey

    World Journal of Emergency Surgery, Vol. 18

  6. Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality

    Open Respiratory Archives, Vol. 5, Núm. 3

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

    BMC Cancer, Vol. 22, Núm. 1

  3. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  4. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the thoracic tumor registry

    PLoS ONE, Vol. 16, Núm. 6 June

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study

    Journal of Clinical Anesthesia, Vol. 74

  4. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain

    Medicina Clinica, Vol. 156, Núm. 2, pp. 61-64

  5. Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study

    Head & neck, Vol. 43, Núm. 12, pp. 3743-3756